Cargando…
Aberrant Non-Coding RNA Expression in Patients with Systemic Lupus Erythematosus: Consequences for Immune Dysfunctions and Tissue Damage
Systemic lupus erythematosus (SLE) is a complex systemic autoimmune disease with heterogeneous clinical manifestations. A diverse innate and adaptive immune dysregulation is involved in the immunopathogenesis of SLE. The dysregulation of immune-related cells may derive from the intricate interaction...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7762297/ https://www.ncbi.nlm.nih.gov/pubmed/33291347 http://dx.doi.org/10.3390/biom10121641 |
_version_ | 1783627771849736192 |
---|---|
author | Tsai, Chang-Youh Shen, Chieh-Yu Liu, Chih-Wei Hsieh, Song-Chou Liao, Hsien-Tzung Li, Ko-Jen Lu, Cheng-Shiun Lee, Hui-Ting Lin, Cheng-Sung Wu, Cheng-Han Kuo, Yu-Min Yu, Chia-Li |
author_facet | Tsai, Chang-Youh Shen, Chieh-Yu Liu, Chih-Wei Hsieh, Song-Chou Liao, Hsien-Tzung Li, Ko-Jen Lu, Cheng-Shiun Lee, Hui-Ting Lin, Cheng-Sung Wu, Cheng-Han Kuo, Yu-Min Yu, Chia-Li |
author_sort | Tsai, Chang-Youh |
collection | PubMed |
description | Systemic lupus erythematosus (SLE) is a complex systemic autoimmune disease with heterogeneous clinical manifestations. A diverse innate and adaptive immune dysregulation is involved in the immunopathogenesis of SLE. The dysregulation of immune-related cells may derive from the intricate interactions among genetic, epigenetic, environmental, and immunological factors. Of these contributing factors, non-coding RNAs (ncRNAs), including microRNAs (miRNAs, miRs), and long non-coding RNAs (lncRNAs) play critical roles in the post-transcriptional mRNA expression of cytokines, chemokines, and growth factors, which are essential for immune modulation. In the present review, we emphasize the roles of ncRNA expression in the immune-related cells and cell-free plasma, urine, and tissues contributing to the immunopathogenesis and tissue damage in SLE. In addition, the circular RNAs (circRNA) and their post-translational regulation of protein synthesis in SLE are also briefly described. We wish these critical reviews would be useful in the search for biomarkers/biosignatures and novel therapeutic strategies for SLE patients in the future. |
format | Online Article Text |
id | pubmed-7762297 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-77622972020-12-26 Aberrant Non-Coding RNA Expression in Patients with Systemic Lupus Erythematosus: Consequences for Immune Dysfunctions and Tissue Damage Tsai, Chang-Youh Shen, Chieh-Yu Liu, Chih-Wei Hsieh, Song-Chou Liao, Hsien-Tzung Li, Ko-Jen Lu, Cheng-Shiun Lee, Hui-Ting Lin, Cheng-Sung Wu, Cheng-Han Kuo, Yu-Min Yu, Chia-Li Biomolecules Review Systemic lupus erythematosus (SLE) is a complex systemic autoimmune disease with heterogeneous clinical manifestations. A diverse innate and adaptive immune dysregulation is involved in the immunopathogenesis of SLE. The dysregulation of immune-related cells may derive from the intricate interactions among genetic, epigenetic, environmental, and immunological factors. Of these contributing factors, non-coding RNAs (ncRNAs), including microRNAs (miRNAs, miRs), and long non-coding RNAs (lncRNAs) play critical roles in the post-transcriptional mRNA expression of cytokines, chemokines, and growth factors, which are essential for immune modulation. In the present review, we emphasize the roles of ncRNA expression in the immune-related cells and cell-free plasma, urine, and tissues contributing to the immunopathogenesis and tissue damage in SLE. In addition, the circular RNAs (circRNA) and their post-translational regulation of protein synthesis in SLE are also briefly described. We wish these critical reviews would be useful in the search for biomarkers/biosignatures and novel therapeutic strategies for SLE patients in the future. MDPI 2020-12-06 /pmc/articles/PMC7762297/ /pubmed/33291347 http://dx.doi.org/10.3390/biom10121641 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Tsai, Chang-Youh Shen, Chieh-Yu Liu, Chih-Wei Hsieh, Song-Chou Liao, Hsien-Tzung Li, Ko-Jen Lu, Cheng-Shiun Lee, Hui-Ting Lin, Cheng-Sung Wu, Cheng-Han Kuo, Yu-Min Yu, Chia-Li Aberrant Non-Coding RNA Expression in Patients with Systemic Lupus Erythematosus: Consequences for Immune Dysfunctions and Tissue Damage |
title | Aberrant Non-Coding RNA Expression in Patients with Systemic Lupus Erythematosus: Consequences for Immune Dysfunctions and Tissue Damage |
title_full | Aberrant Non-Coding RNA Expression in Patients with Systemic Lupus Erythematosus: Consequences for Immune Dysfunctions and Tissue Damage |
title_fullStr | Aberrant Non-Coding RNA Expression in Patients with Systemic Lupus Erythematosus: Consequences for Immune Dysfunctions and Tissue Damage |
title_full_unstemmed | Aberrant Non-Coding RNA Expression in Patients with Systemic Lupus Erythematosus: Consequences for Immune Dysfunctions and Tissue Damage |
title_short | Aberrant Non-Coding RNA Expression in Patients with Systemic Lupus Erythematosus: Consequences for Immune Dysfunctions and Tissue Damage |
title_sort | aberrant non-coding rna expression in patients with systemic lupus erythematosus: consequences for immune dysfunctions and tissue damage |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7762297/ https://www.ncbi.nlm.nih.gov/pubmed/33291347 http://dx.doi.org/10.3390/biom10121641 |
work_keys_str_mv | AT tsaichangyouh aberrantnoncodingrnaexpressioninpatientswithsystemiclupuserythematosusconsequencesforimmunedysfunctionsandtissuedamage AT shenchiehyu aberrantnoncodingrnaexpressioninpatientswithsystemiclupuserythematosusconsequencesforimmunedysfunctionsandtissuedamage AT liuchihwei aberrantnoncodingrnaexpressioninpatientswithsystemiclupuserythematosusconsequencesforimmunedysfunctionsandtissuedamage AT hsiehsongchou aberrantnoncodingrnaexpressioninpatientswithsystemiclupuserythematosusconsequencesforimmunedysfunctionsandtissuedamage AT liaohsientzung aberrantnoncodingrnaexpressioninpatientswithsystemiclupuserythematosusconsequencesforimmunedysfunctionsandtissuedamage AT likojen aberrantnoncodingrnaexpressioninpatientswithsystemiclupuserythematosusconsequencesforimmunedysfunctionsandtissuedamage AT luchengshiun aberrantnoncodingrnaexpressioninpatientswithsystemiclupuserythematosusconsequencesforimmunedysfunctionsandtissuedamage AT leehuiting aberrantnoncodingrnaexpressioninpatientswithsystemiclupuserythematosusconsequencesforimmunedysfunctionsandtissuedamage AT linchengsung aberrantnoncodingrnaexpressioninpatientswithsystemiclupuserythematosusconsequencesforimmunedysfunctionsandtissuedamage AT wuchenghan aberrantnoncodingrnaexpressioninpatientswithsystemiclupuserythematosusconsequencesforimmunedysfunctionsandtissuedamage AT kuoyumin aberrantnoncodingrnaexpressioninpatientswithsystemiclupuserythematosusconsequencesforimmunedysfunctionsandtissuedamage AT yuchiali aberrantnoncodingrnaexpressioninpatientswithsystemiclupuserythematosusconsequencesforimmunedysfunctionsandtissuedamage |